CITATION & INNOVATION AWARDS 2012
Twelve Australian researchers have been selected to receive Citation Awards in recognition of their outstanding contribution to research. In addition, seven Australian organisations have been recognised for their excellence in innovation.
Thomson Reuters congratulates the 2012 Citation and Innovation Award winners!
- Citation Awardees
Research Field: Astronomy & Astrophysics
Professor Karl Glazebrook
Swinburne University of Technology
Professor Karl Glazebrook is a University Distinguished Professor at Swinburne University. Karl’s research involves the areas of galaxy evolution over cosmic time, cosmology and astronomical instrumentation; he is an observational astronomer who uses large telescopes on the ground such as Keck, Gemini and the Hubble Space Telescope.
Originally from the UK, Karl completed his PhD at Edinburgh (1992) and post-doctoral work in Durham and Cambridge before becoming a Staff Astronomer at the Anglo-Australian Observatory in Sydney. Karl became a Professor at Johns Hopkins University in Baltimore in the year 2000 and moved to Swinburne in 2006.
Research Field: Biochemistry & Molecular Biology
Professor Terry Speed
The Walter and Eliza Hall Institute of Medical Research
Professor Terry Speed is head of the Bioinformatics Division of the Walter & Eliza Hall Institute of Medical Research (WEHI). Originally trained in mathematics and statistics, he has had a lifelong interest in genetics.
After teaching mathematics and statistics in universities in Australia and the United Kingdom, and a spell in the CSIRO’s Division of Mathematics and Statistics, he went to the Department of Statistics at the University of California, Berkeley (UC Berkeley) in 1987. Since that time his research and teaching interests have concerned the application of statistics to genetics and molecular biology. Within that subfield, eventually to be named bioinformatics, his interests are broad, including biomolecular sequence analysis, the mapping of genes in experimental animals and humans, and functional genomics.
He has been particularly involved in the low-level analysis of microarray data, and more recently, of next-generation DNA sequence analysis. From 1997 to 2009 he split his time 50:50 between WEHI and UC Berkeley. In 2009 he took up an NHMRC Australia Fellowship at WEHI and became emeritus professor at UC Berkeley, but he still has students, postdocs and collaborators there.
Research Field: Biodiversity Conservation
Dr Jane Elith
The University of Melbourne
Dr Jane Elith is appointed as a research fellow at the University of Melbourne, funded by an ARC Future Fellowship. Her research spans theoretical, methodological, and applied aspects of methods for modelling and predicting distributions of species and communities, reflecting her interest in biodiversity and conservation and attraction towards quantitative methods.
Jane’s projects have spanned terrestrial, freshwater and marine ecosystems, with a substantial emphasis on finding appropriate methods and making them accessible to end-users. Most recently Jane has started working on problems associated with modelling non-equilibrial situations, exploring appropriate methods for predicting both the potential spread of invasive species and the likely responses of the biota to climate change.
Research Field: Ecology
Professor Ove Hoegh-Guldberg
The University of Queensland
Professor Ove Hoegh-Guldberg (BSc Hons., Sydney; PhD. UCLA) is the inaugural Director of the Global Change Institute (GCI) (www.gci.uq.edu.au) and Professor of Marine Science, at The University of Queensland (UQ) (www.uq.edu.au), Brisbane, Australia. He is deeply-motivated by a desire to communicate science effectively, undertake game-changing research and to find high-impact solutions to address several of the most pressing and serious challenges facing humanity worldwide, such as climate change, food security, clean energy and population growth.
As Director of the GCI Ove has a key role in engaging with the UQ community and external stakeholders to create opportunities and build strong external links and networks for the institute. He heads a large research laboratory (over 30 researchers & students) that focuses on how global warming and ocean acidification are affecting and will affect coral reefs.
Ove has held academic positions at UCLA, Stanford University, The University of Sydney and The University of Queensland and is a member of the Australian Climate Group; the Royal Society (London) Marine Advisory Network; and the Board of Editing Reviewers at Science Magazine. In 1999 he was awarded the Eureka Prize for his scientific research. He is the Queensland Smart State Premier’s Fellow (2008-2013).
Research Field: Economics
Dr Thomas Wiedmann
Dr Thomas (Tommy) Wiedmann is a Senior Research Scientist at CSIRO Ecosystem Sciences, Canberra, where he is involved with CSIRO’s Integrated Carbon Pathways project. His research fields are environmental input-output analysis, industrial ecology and sustainable consumption and production. Tommy develops and applies methods and models for integrated sustainability and scenario analysis. In 2009, he was the guest editor of a special issue of the journal Economic Systems Research on ‘Carbon Footprint and Input-Output Analysis’.
Tommy is also an Adjunct Associate Professor at the Centre for Integrated Sustainability Analysis (ISA) in the School of Physics at the University of Sydney and Director at the Centre for Sustainability Accounting (CenSA) in York, UK. He has coordinated a number of research projects funded by European, UK and Australian Governments. Tommy holds a PhD in environmental and analytical chemistry from the University Of Ulm, Germany.
Research Field: Environmental Studies
Dr Shaobin Wang
Curtin University of Technology
Dr Shaobin Wang graduated from the University of Queensland with a PhD degree in chemical engineering. Currently he is an associate professor at Department of Chemical Engineering, Curtin University. His research areas focus on Nanomaterials, applied catalysis and environmental engineering. He has published more than 180 refereed journal and conference papers and he is on the editorial board of several international journals in catalysis and environmental science.
Research Field: Geosciences
Professor Kurt Lambeck
Australian National University
Professor Kurt Lambeck’s research deals with the motions and deformations of the Earth, on time scales from hours to millions of years, with the objective of understanding the forces that shape the planet, including the interactions of the oceans, atmosphere and cryosphere with the solid part of the earth. He is the leading proponent of developing and integrating geodetic methods with other geoscience disciplines of geophysics, geology and environmental science and over a career of more than three decades he has played a central role in most of the significant advances in this field.
His studies have led to improved understanding of the orbital movements of earth satellites, of the dynamics of the Earth system, and to predictive models of the planet’s behaviour. These contributions have crossed diverse sub-disciplines of geoscience but they all have the common goal of understanding the dynamics of the Earth system over a broad range of time and length scales.
Kurt Lambeck is the immediate past president of the Australian Academy of Science and professor emeritus at the Australian National University. Currently he holds a Blaise Pascal Chair at the Ecole Normale Superieure, Paris. He is, amongst others, a member of the Royal Society, the French Academy of Science, and the US National Academy of Science.
Research Field: Immunology
Professor Fabienne Mackay
Professor Fabienne Mackay obtained her Ph D in 1994 at the Louis Pasteur University in Strasbourg under the co-supervision of Dr Werner Lesslauer (Hoffmann La Roche, Basel Switzerland) and Prof. Diane Mathis (now at the Joslin Institute Boston USA). In 1994, Fabienne joined Biogen Idec Inc. in Boston where she dissected the role of a TNF-like ligand lymphotoxin-alpha/beta in autoimmunity and cancer. This work led to many patents and the development of two new treatments currently tested in the clinic.
In 2000, Fabienne joined the Garvan Institute in Sydney as a Welcome Trust senior research fellow and was awarded a NHMRC program grant. Fabienne’s lab at the Garvan discovered the role of a new molecule named BAFF as a key B cell survival factor essential for the maturation of B-lymphocytes but also playing a role in autoimmunity, and became the leading group on BAFF research. In March 2006, Fabienne was appointed to Director of the Autoimmunity Research Unit and adjunct full professor at the Faculty of medicine of the University of New South Wales. Fabienne is a consultant for several biotech and pharmaceutical groups. In 2007, she joined the national director board of the Australian Society of Medical Research (ASMR). In 2008, she was the NSW representative for the NHMRC Association for Research Fellows (NARF). Fabienne is an associate editor for several scientific journals including the Journal of Interferon & Cytokine Research and the European Journal of Immunology.
In March 2009, Fabienne became the 5th Chair of the Department of Immunology, Monash University, AMREP campus. In July 2009, belimumab, a therapeutic antibody neutralising BAFF has met the primary endpoints in a phase III clinical trial with lupus patients and run by GSK and Human Genome Sciences. This clinical outcome validated a decade of Fabienne’s work on BAFF and autoimmunity.
Research Field: Neuroscience
Professor Greg Stuart
The Australian National University
Professor Greg Stuart is currently Head of the Eccles Institute of Neuroscience at the John Curtin School of Medical Research at the Australian National University. He did his undergraduate at Monash University, majoring in Physiology, before going on to do a PhD in Neuroscience at the ANU. He has developed and pioneered methods that have allowed neuroscientists to probe the function of nerve cells at an unprecedented level, and is considered a world expert on the physiology of neuronal dendrites.
He has received a number of national and international fellowships and awards, and was recently appointed to the Australian Academy of Science in recognition of his seminal contributions to understanding how information is processed by individual nerve cells within the brain.
Research Field: Plant Sciences
Professor Rana Munns
Professor Rana Munns has worked towards improving crop production on soils that are dry or saline. She is now Honorary Fellow at CSIRO Plant Industry in Canberra, as well as Winthrop Professor at the University of Western Australia. She is a Fellow of the Australian Academy of Science. She is recognised internationally for her insights into the fundamental principles of salt tolerance, and for the applications of these insights.
She characterised the critical processes for tolerance of salinity stress, and showed how these differ from tolerance of drought stress. This work produced a highly sensitive technique for identifying salt tolerant plants, and the discovery of important genes for salt tolerance. She led a research team that discovered novel genes for controlling sodium transport in ancestral wheat, crossed them into modern durum wheat, and showed that these increased yield in saline soil in farmers’ fields by 25%. This work has just been published in Nature Biotechnology.
Research Field: Psychology
Professor Colin MacLeod
The University of Western Australia
Professor Colin MacLeod is Winthrop Professor of Psychology, Australian Research Council Professorial Fellow, and Director of the Elizabeth Rutherford Memorial Centre for the Advancement of Research on Emotion (CARE), at the University of Western Australia (UWA). Colin completed training both as a cognitive psychologist, carrying out his research doctorate in this field at Oxford University, and as a clinician, undertaking clinical psychology training at the Institute of Psychiatry, University of London. Across his subsequent career, he has sought to harness these two distinctive facets of his discipline to shed light on the cognitive basis of emotional vulnerability and pathology. His work has been guided by three complementary objectives: 1) to delineate the patterns of selective information processing that characterise emotional vulnerability and dysfunction; 2) to determine the causal nature of the association between each such processing bias and emotional disposition; and 3) to design and evaluate methods of attenuating emotional vulnerability by directly altering the cognitive biases that operate to functionally sustain it. He has played a major role in the development of influential new intervention approaches that contribute to the treatment of emotional dysfunction, and related clinical conditions, through the use of computer-based cognitive bias modification procedures.
Colin joined the Australian tertiary sector in 1987, and commenced his position at The University of Western Australia in 1989. Since then, his research has been continuously funded by the Australian Research Council, and by a range of international granting agencies. He was elected a Fellow of the Academy of Social Sciences in Australia in 2002. Colin has held recent editorial positions with the Journal of Abnormal Psychology, Cognitive Therapy and Research, the Journal of Behaviour Therapy and Experimental Psychiatry, and Emotion, and has carried out a wide variety of responsibilities within the Australian University context. He has served as Head of Psychology, Associate Dean of Research, Chair of Academic Board, acting Pro Vice-Chancellor (Research & Innovation), national auditor for Australian University Quality Agency, and international auditor for overseas university quality agencies, including South Africa’s Council of Higher Education, and Saudi Arabia’s National Commission for Academic Accreditation and Assessment.
Research Field: Public, Environmental & Occupational Health
Dr Evie Leslie
Dr Evie Leslie is a senior researcher and behavioural scientist who took up her current role in the School of Medicine at Flinders University in early 2012. Previously she was a Principal Research Fellow at Deakin University, and has held appointments at the University of Wollongong and the University of Queensland. Her research has a population health focus, with particular interests in healthy lifestyles (physical activity and nutrition behaviours), community health promotion and the role of community design and green spaces in maintaining health and well-being. Currently Evie is the coordinator for the evaluation of a large community-based obesity prevention program called OPAL (Obesity Prevention and Lifestyle) which will be operating in 20 communities in South Australia by the end of 2012.
Evie has completed an advanced training course on physical activity and public health at the US Centres for Disease Control and conducted her own program of research through an NHMRC Public Health Training Fellowship, examining the impacts of social and physical environments on physical activity behaviours. Her work includes innovative approaches linking behavioural and spatial epidemiology methods and she has published extensively on the ‘walkability’ of communities. Over her career she has worked with various government departments on research-related projects and has contributed to several evidence-based policy documents. She collaborates with researchers from a variety of disciplines including epidemiology, public health, urban planning, social geography, health psychology, exercise science, nutrition, medicine and behavioural epidemiology.
- Innovation Awardees
Innovation Category: Corporate – Bio/Med (Large)
ResMed (NYSE: RMD and ASX: RMD.AX) is a leading developer, manufacturer and distributor of medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders. The company is dedicated to developing innovative products to improve the lives of those who suffer from these conditions and to increasing awareness among patients and healthcare professionals of the potentially serious health consequences of untreated sleep-disordered breathing.
When ResMed was formed in 1989, its primary purpose was to commercialise a device for treating obstructive sleep apnea (OSA), a major subset of SDB. Developed in 1981 by Professor Colin Sullivan and colleagues at the University of Sydney, nasal continuous positive airway pressure (CPAP) provided the first successful non-invasive treatment of OSA. Since 1989, ResMed has maintained its focus on SDB, which is gaining greater public and physician awareness. Operations have grown dramatically through the introduction of a number of highly innovative product lines.
Innovation Category: Corporate – Bio/Med (SME)
CathRx is focussed on developing, patenting and producing a full range of high quality Electrophysiology (EP) Catheters, used in the diagnosis and treatment of cardiac arrhythmias. CathRx’s goal is to provide high quality EP Catheters at costs that will make EP procedures far more affordable. CathRx design a full range of EP Catheters, featuring durable materials to ensure high performance during use. CathRx also produce catheters that have a unique, patented design feature: Modular Construction. This enables manufacturing and remanufacturing with selected partners globally to drive huge hospital savings.
CathRx is the only Catheter technology company in the world that offers Remanufacturable Catheters. This offers hospitals EP Catheters that have passed the same quality control tests that all new Catheters must pass, but at significantly reduced prices. CathRx has also designed and patented an Advanced AF Ablation program, which uses irrigated, multi-electrode, linear lesion technology. This technology has the potential to help patients worldwide with a safe and effective AF Ablation system.
Innovation Category: Corporate – Tech (Large)
Rio Tinto Ltd
Rio Tinto is a leading international mining group, combining Rio Tinto plc, a London listed public company headquartered in the UK, and Rio Tinto Limited, which is listed on the Australian Stock Exchange, with executive offices in Melbourne. The two companies are joined in a dual listed companies (DLC) structure as a single economic entity, called the Rio Tinto Group.
To deliver superior returns to shareholders over time, Rio Tinto takes a long term and responsible approach to the Group’s business. This means concentrating on the development of first class orebodies into large, long life and efficient operations, capable of sustaining competitive advantage through business cycles. Rio Tinto is a world leader in finding, mining and processing the Earth’s mineral resources. Our products help fulfil vital consumer needs and improve living standards. Rio Tinto operate, and eventually close, our operations safely, responsibly and sustainably.
Rio Tinto’s interests are diverse both in geography and product. Rio Tinto work in some of the world’s most difficult terrains and climates. Most of their assets are in Australia and North America, but they also operate in Europe, South America, Asia and Africa. Their businesses include open pit and underground mines, mills, refineries and smelters as well as a number of research and service facilities.
Rio Tinto operates as a global organisation, sharing best practices across the Group. Their values - accountability, respect, teamwork and integrity - are expressed through their business principles, policies and standards. Rio Tinto set these out in our worldwide code of business conduct, the way they work. Their values underpin the way they manage the economic, social and environmental effects of their operations, and how they govern their business.
Innovation Category: Corporate – Tech (SME)
Demain International Pty Ltd
Demain is the world’s largest independent developer specialising in power tools and uses its unique ICADS (Innovation Creation and Development System) to deliver genuine improvement to the user in the areas of safety, endurance, comfort, control, ergonomics and speed of a power tool.
Demain International P/L was founded in 2001 with the aim of designing and developing true power tool innovation for the global market. Since 2001, Demain has developed a portfolio of innovation that includes market leading technologies such as Power-Tite™, Air Thru™ and Flashcell™. Demain International’s highly awarded innovations and technologies have been implemented in power tools in most of the major markets of the world.
Innovation Category: Government Funded
The Grains Research & Development Corporation
The Grains Research & Development Corporation is one of the world’s leading grains research organisations, responsible for planning, investing and overseeing research and development (R&D), delivering improvements in production, sustainability and profitability across the Australian grains industry. GRDC is a statutory corporation, founded in 1990 under the Primary Industries and Energy Research and Development Act 1989 (PIERD Act), it is subject to accountability and reporting obligations set out in the Commonwealth Authorities and Companies Act 1997 (CAC Act). The GRDC’s portfolio department is the Australian Government Department of Agriculture, Fisheries and Forestry (DAFF).
The GRDC’s mission is to invest in R&D for the greatest benefit to its stakeholders - grain growers and the Australian Government. This involves coordinating and funding the activities; monitoring, evaluating and reporting on their impact; and facilitating the dissemination, adoption and commercialisation of their results. The GRDC also contributes to the development of strategic national approaches to grains industry R&D, to reduce fragmentation and duplication, and to help address industry-wide issues such as biosecurity and climate change. The Corporation links innovative research with industry needs. The GRDC’s vision is for a profitable, internationally competitive and ecologically sustainable grains industry.
Collaboration is at the heart of the GRDC’s approach to adding value to the Australian grains industry. The majority of the GRDC’s investment in R&D is with partners that co-fund the work as well as conducting the activities. This includes partnerships to provide a path to market for the results of R&D projects.
The GRDC’s research portfolio covers 25 leviable crops spanning temperate and tropical cereals, oilseeds and pulses, worth over $7 billion a year in farm production, alone. Funding is provided through a levy on grain growers. This is determined each year by the grains industry’s peak body. The Australian Government matches this funding, up to an agreed ceiling.
Innovation Category: University
The University of New South Wales
The University of New South Wales is one of Australia’s leading research and teaching universities. At UNSW, they take pride in the broad range and high quality of our teaching programs. UNSW’s teaching gains strength and currency from their research activities and international nature; they have a strong regional and global engagement.
In developing new ideas and promoting lasting knowledge UNSW are creating an academic environment where outstanding students and scholars from around the world can be inspired to excel in their programs of study and research. Partnerships with both local and global communities allow UNSW to share knowledge, debate and research outcomes. UNSW’s public events include concert performances, open days and public forums on issues such as the environment, healthcare and global politics.
Innovation Category: Collaboration
The University of Queensland
The University of Queensland (UQ) is one of Australia’s premier learning and research institutions. It is the oldest university in Queensland and has produced almost 197,000 graduates since opening in 1911. Its graduates have become leaders in all areas of society and industry. UQ is one of the three Australian members of the global Universitas 21 alliance. This group aims to enhance the quality of university outcomes through international benchmarking and a joint venture e-learning project with The Thomson Corporation.
UQ is a founding member of the national Group of Eight (Go8) a coalition of leading Australian universities, intensive in research and comprehensive in general and professional education. Collectively, Group of Eight members account for 70 percent of all research income in Australia’s university system, enrol more than half of all higher degree by research students, hold over 90 percent of US patents for inventions and generate 80 percent of spin-off companies created by Australian universities. UQ is a pacesetter in discovery and translational research across a broad spectrum of exciting disciplines, ranging from bioscience and nanotechnology to mining, engineering, social science and humanities.
Its eight internationally significant research institutes are drawcards for an ever-expanding community of scientists, researchers and commercialisation experts. UQ is noted for supporting early- and mid-career researchers, as seen in their commitment to research training; in 2010, UQ celebrated its 9000th PhD graduation. UQ currently has 4039 Research Higher Degree students, including 3593 PhD students. In 2010, 534 Research Higher Degrees were awarded.
Eden Energy Ltd is a diversified clean energy company that listed on the Australian Stock Exchange in May 2006. Eden has interests in hydrogen production, storage and transport fuel systems, including the low emission Hythane hydrogen-methane blend, coal seam and abandoned mine methane in the UK, conventional gas in SA, low temperature pyrolysis research into hydrogen production and geothermal energy production.
All these aspects of Eden’s business are part of an integrated strategy to become a major global participant in the alternate energy market, particularly focussing on the clean energy transport market, producing hydrogen without any carbon emissions, transporting the hydrogen to markets and providing the engines to power hydrogen-based transport and energy solutions.
Methodology - Citation Awards 2012
This exploration of Australian research began with an identification of fields which were strengths for the country, by a combination of three criteria: first, how many papers Australian researchers published; second, how great a proportion of the field globally Australian research represented; and third, the level of impact, measured in citations, relative to global performance in the field.
The next step was to consider individuals who contribute to those fields. All Australian-affiliated authors from papers published between 2002 and October 2011, in journals indexed in Thomson Reuters’ Web of Science, were reviewed. A shortlist of researchers in each field was established by finding those authors who had published a given number of papers, each of which had been cited that given number of times – a metric called the h-index. This meant that only researchers who had made a strong contribution in terms of both quality and quantity were considered. Because field activity can vary widely, adjustments were made in the threshold levels for each field to eliminate false leads and focus on those researchers with substantial and long-term contributions.
The shortlist was then ranked by average citations per paper received, and the highest ranking author currently and actively producing research output was identified. This ensured that researchers would be selected who had a proven track record of high-impact research over the course of the ten year period. Where variation between the top and second ranked candidates was less than one citation per article, a second metric, average percentile, was used to differentiate them. This metric looks at how highly ranked a paper is by citations against papers of the same type, published in the same year and in the same field, thereby allowing accurate comparison of the candidates’ impact.
Methodology - Innovation Awards 2012
The methodology used to determine the 2012 Australian Innovation Award winners is based closely on the methodology used in the Thomson Reuters Top 100 Global Innovators Program. The methodology used to determine the Top 100 Global Innovators was developed by Thomson Reuters and discussed with and approved by several IP-savvy, external organisations.
This is the first time Thomson Reuters has awarded innovation and entrepreneurship in Australia. Seven awards are presented: Large Corporate and SME Corporate (Biotechnology/Medical Devices), Large Corporate and SME Corporate (Technology), Government Funded R&D, University R&D and Best Academic/Corporate Collaboration. The awards recognise Australian innovation resulting from institutions and large and Small-to-Medium sized (SME) commercial enterprises headquartered in Australia. Australian SME Corporations are those with less than 200 employees.
The research and analyses used to determine the award winners was performed using Thomson Reuters’ Derwent World Patents Index® (DWPI), Thomson Innovation®, the Thomson Reuters IP intelligence and collaboration platform, and Thomson Data Analyzer®. Four indicators were used to determine the winners:
VOLUME: The top 10 most prolific patent filers in Australia over the last 5 years were identified. These organisations became the "candidate organisations".
SUCCESS: For each candidate organisation, the number of granted patents to total number of new inventions filed in the last 5 years was used as a measure of "success".
GLOBALISATION: The number of inventions filed in the last 5 years that have quadrilateral patents in their patent families, according to the Thomson Reuters Quadrilateral Patent Index™ was calculated for each candidate organisation.
INFLUENCE: The impact of an invention can be determined by looking at how often it is subsequently cited down the line. Citation counts were determined for each of the candidate organisations to provide a measure of the "influence" of their inventions filed in the last 5 years.
These indicators were used in combination to identify the 2012 Australian Innovation Award winners.
For more details on the methodology used to determine the 2012 Innovation Award winners, review the Research Brief below:
30 May 2012 ABC National Press Club: Brian Schmidt and Alan Finkel
30 May 2012 ABC1 Canberra Repeat Broadcast: National Press Club: Brian Schmidt and Alan Finkel
30 May 2012 ABC Newcastle Repeat Broadcast: National Press Club: Brian Schmidt and Alan Finkel
30 May 2012 ABC Newcastle Regular Segment: The Agenda.
1 June 2012 5AA Adelaide A Flinders University researcher has been named one of the 12 most influential Australian researchers in the Thomson Reuters Australia Citation and Innovation Awards.
31 May 2012 The Australian Higher Education How to breed 'hot' researchers".
31 May 2012 Sydney Morning Herald Chancellor slams uni fee system as communist.
31 May 2012 BrisbaneTimes Chancellor slams uni fee system as communist.
31 May 2012 The Australian 'Anti-science culture' hurting our future.
31 May 2012 Age Chancellor slams uni fee system as communist.
31 May 2012 Daily Advertiser Nobel laureate eyeing future.
4 June 2012 Campus Review Scientists recognised in citation awards.
14 June 2012 City News, Brisbane Sought after research
14 June 2012 Countryman, Perth UWA plant biologist recognised
19 Jun 2012 Western Suburbs Weekly, Perth PROF REAPS AWARD
30 May 2012 Nine MSN Science must engage with overseas: Schmidt.
30 May 2012 The Conversation Top-cited academics honoured (but where's the humanity?)
30 May 2012 NHMRC CEO Congratulates Recipients of Thomson Reuters Australian Citation and Innovation Award.
30 May 2012 KnowledgeSpeak Thomson Reuters recognises Australia's contribution to global research and innovation.
30 May 2012 ANU News Most influential researchers announced.
30 May 2012 Flinders News Flinders researcher in Thomson Reuters top 12.
30 May 2012 University of Western Australia Plant biologist wins national award.
30 May 2012 University of Western Australia National award for pioneering psychologist.
30 May 2012 Global Change Institute Australian ecologist among world's top scientists.
30 May 2012 University of Queensland Australian ecologist among world's top scientists.
30 May 2012 FB Rice FB Rice at the Citation & Innovation Awards in Canberra.
30 May 2012 Monash University Lupus pioneer receives prestigious award.
30 May 2012 Walter and Eliza Hall Institute Leading statistician receives national citation award.
30 May 2012 PhysOrg.com Leading statistician receives national citation award.
30 May 2012 Swinburne Media Centre News: Karl Glazebrook earns prestigious citation.
30 May 2012 Campus Daily Karl Glazebrook earns prestigious citation.
30 May 2012 Curtin University 2012 Thomson Reuters Australia Citation and Innovation Awards.
1 June 2012 Group of Eight (Go8) June issue.
1 June 2012 in-business South Australia Flinders public health researcher among worlds most influential.
1 June 2012 ATN in Profile The ATN congratulates Dr Shaobin Wang.
11 June 2012 CathRx CathRx receives prestigious Innovation Award.
21 Jun 2012 Indaily's Blog Leslie in Thomson Reuters top 12.
The Science and Art of Using Citation
Indicators to Identify Exceptional Scientists and their
Impact 1.89 MB David
How Australia is influencing the global
research and innovation landscape: academic
perspective 76 KB
Professor Ove Hoegh-Guldberg
How Australia is influencing the global
research and innovation landscape: academic
perspective 99 KB
Professor Colin MacLeod
- Metrics & Methodology for the Innovation Awards 781 KB Dr Nicola Lake
- The Science and Art of Using Citation Indicators to Identify Exceptional Scientists and their Impact 1.89 MB David Pendlebury